Close
Found 0 results for your search. Showing 0 to 0.
No results could be found for your search.
x Close Search
Close

Publications

A non-exhaustive repository of COVID-19 related scientific publications undertaken by LSHTM researchers since the beginning of the outbreak.

Geographic and temporal variation in racial and ethnic disparities in SARS-CoV-2 positivity between February 2020 and August 2021 in the United States.
Ferguson, JM; Justice, AC; Osborne, TF; Magid, HS A; Purnell, AL; RENTSCH, CT;
2021
Scientific Reports, (2021).12 1 10.1038/s41598-021-03967-5.
The Interplay Between Strictness of Policies and Individuals' Self-Regulatory Efforts: Associations with Handwashing During the COVID-19 Pandemic.
Luszczynska, A; Szczuka, Z; Abraham, C; Baban, A; Brooks, S; Cipolletta, S; DANSO, E; Dombrowski, SU; Gan, Y; Gaspar, T; De Matos, MG; Griva, K; Jongenelis, MI; Keller, J; Knoll, N; Ma, J; Miah, MA A; Morgan, K; Peraud, W; Quintard, B; SHAH, V; Schenkel, K; Scholz, U; Schwarzer, R; Siwa, M; ... Wolf, H.
2021
Annals of Behavioral Medicine, (2021).56 4 10.1093/abm/kaab102.
"Other risks don't stop": adapting a youth sexual and reproductive health intervention in Zimbabwe during COVID-19.
MACKWORTH-YOUNG, CR S; MAVODZA, C; Nyamwanza, R; Tshuma, M; Nzombe, P; DZIVA CHIKWARI, C; TEMBO, M; Dauya, E; Apollo, T; FERRAND, RA; BERNAYS, S;
2021
Sexual and Reproductive Health Matters, (2021).30 1 10.1080/26410397.2022.2029338.
National health governance, science and the media: drivers of COVID-19 responses in Germany, Sweden and the UK in 2020.
HANSON, C; Luedtke, S; SPICER, N; Stilhoff Sörensen, J; MAYHEW, S; MOUNIER-JACK, S;
2021
BMJ GLOBAL HEALTH, (2021).6 12 10.1136/bmjgh-2021-006691.
How immunity from and interaction with seasonal coronaviruses can shape SARS-CoV-2 epidemiology.
WATERLOW, NR; VAN LEEUWEN, E; DAVIES, NG; CMMID COVID-19 Working Group,; FLASCHE, S; EGGO, RM;
2021
Proceedings of the National Academy of Sciences of the United States of America, (2021).118 49 10.1073/pnas.2108395118.
Comparing human and model-based forecasts of COVID-19 in Germany and Poland.
BOSSE, NI; ABBOTT, S; Bracher, J; Hain, H; Quilty, BJ; JIT, M; Van Leeuwen, E; Cori, A; FUNK, S;
2021
(2021). 10.1101/2021.12.01.21266598.
CD19 B cell repopulation after ocrelizumab, alemtuzumab and cladribine: Implications for SARS-CoV-2 vaccinations in multiple sclerosis.
Baker, D; MACDOUGALL, A; Kang, AS; Schmierer, K; Giovannoni, G; Dobson, R;
2021
Multiple Sclerosis and Related Disorders, (2021).57, 10.1016/j.msard.2021.103448.
Precautionary breaks: Planned, limited duration circuit breaks to control the prevalence of SARS-CoV2 and the burden of COVID-19 disease.
Keeling, MJ; Guyver-Fletcher, G; Dyson, L; Tildesley, MJ; Hill, EM; MEDLEY, GF;
2021
EPIDEMICS, (2021).37, 10.1016/j.epidem.2021.100526.
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial.
Munro, AP S; Janani, L; Cornelius, V; Aley, PK; Babbage, G; Baxter, D; Bula, M; Cathie, K; Chatterjee, K; Dodd, K; Enever, Y; Gokani, K; Goodman, AL; Green, CA; Harndahl, L; Haughney, J; Hicks, A; Van der Klaauw, AA; Kwok, J; Lambe, T; Libri, V; Llewelyn, MJ; McGregor, AC; Minassian, AM; Moore, P; ... COV-BOOST study group,
2021
Lancet, (2021).398 10318 10.1016/S0140-6736(21)02717-3.
Reduced neutralisation of the Delta (B.1.617.2) SARS-CoV-2 variant of concern following vaccination.
Davis, C; Logan, N; Tyson, G; Orton, R; Harvey, WT; Perkins, JS; Mollett, G; Blacow, RM; COVID-19 Genomics UK (COG-UK) Consortium,; Peacock, TP; Barclay, WS; Cherepanov, P; Palmarini, M; Murcia, PR; Patel, AH; Robertson, DL; Haughney, J; THOMSON, EC; Willett, BJ; COVID-19 DeplOyed VaccinE (DOVE) Cohort Study inve,;
2021
PLOS PATHOGENS, (2021).17 12 10.1371/journal.ppat.1010022.